ALTERATIONS IN GAP JUNCTION PROTEIN EXPRESSION IN HUMAN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
2002; Lippincott Williams & Wilkins; Volume: 167; Issue: 2 Part 1 Linguagem: Inglês
10.1016/s0022-5347(01)69118-3
ISSN1527-3792
AutoresHelga Habermann, Vera Ray, Walter Habermann, Gail S. Prins,
Tópico(s)Mass Spectrometry Techniques and Applications
ResumoNo AccessJournal of UrologyErratum1 Feb 2002ALTERATIONS IN GAP JUNCTION PROTEIN EXPRESSION IN HUMAN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCERis correction ofALTERATIONS IN GAP JUNCTION PROTEIN EXPRESSION IN HUMAN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER HELGA HABERMANN, VERA RAY, WALTER HABERMANN, and GAIL S. PRINS HELGA HABERMANNHELGA HABERMANN , VERA RAYVERA RAY , WALTER HABERMANNWALTER HABERMANN , and GAIL S. PRINSGAIL S. PRINS View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)69118-3AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Gap junctions composed of connexin proteins have an essential role in intercellular communication and differentiation. Dysregulation of connexin expression is believed to have a role in carcinogenesis. The human prostate has been reported to express connexin 32 and 43. However, the expression pattern in prostate cancer is controversial, while to our knowledge connexin expression has not been reported in benign prostatic hyperplasia (BPH). To understand the potential involvement in prostate disease connexin 32 and 43 expression was evaluated in a series of normal prostate, BPH and prostate cancer specimens that were surgically removed due to bladder outlet obstruction. Materials and Methods: Frozen sections of 23 normal, 43 BPH and 40 cancer involved prostates were evaluated for the presence, staining intensity and pattern of connexin 32 and 43 by immunocytochemical testing. Results: In all specimens examined connexin 43 stain was punctate along the borders of the basal epithelial cells, whereas connexin 32 immunolocalized to luminal epithelial cells. In normal prostate connexin 43 and 32 were present in 87% and 65% of specimens, respectively, at low to moderate stain intensity. Importantly none of the normal samples were negative foreach connexin. In BPH specimens there was a marked increase in the incidence and intensity of connexin 43 and 32 immunostaining within epithelial cells. In addition, 23% of BPH samples showed strong connexin 43 expression in stromal cells. In contrast, connexin was decreased in prostate cancer specimens, of which 65% and 38% were negative for connexin 43 and 32, respectively, and 28% were negative for each type. In poorly differentiated tumors connexin 43 and 32 were present in only 10% and 40% of tumors, respectively, at low immunostaining intensity. Conclusions: In normal human prostate basal cells communicate via connexin 43 gap junctions, whereas luminal cells communicate via connexin 32 gap junctions. In BPH gap junctional intercellular communication is increased in epithelial and stromal cells, which may have a role in BPH pathogenesis. In prostate cancer gap junctional intercellular communication is decreased, is as indicated by decreased expression of connexin 43 and 32 with severe loss in poorly differentiated prostate cancer. These alterations in connexin expression may have a role in dedifferentiation and tumor progression. References 1 : Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem1996; 238: 1. Crossref, Medline, Google Scholar 2 : Gap junctional communication and development. TINS1989; 12: 12. Medline, Google Scholar 3 : The role of gap junctional intercellular communication in neoplasia. Ann Clin Lab Sci1994; 24: 216. Medline, Google Scholar 4 : Desmosomes: differentiation, development, dynamics and disease. Curr Opin Cell Biol1996; 8: 670. Crossref, Medline, Google Scholar 5 : Molecular interactions in the submembrane plaque of cell-cell and cell-matrix adhesions. Acta Anat1995; 154: 46. Crossref, Medline, Google Scholar 6 : Connexins, connexons, and intercellular communication. Annu Rev Biochem1996; 65: 475. Crossref, Medline, Google Scholar 7 : Multiple gap junction genes are utilized during rat skin and hair development. Development1992; 116: 639. Crossref, Medline, Google Scholar 8 : Developmental regulation and structural organization of connexins in epidermal gap junctions. Dev Biol1994; 164: 183. Crossref, Medline, Google Scholar 9 : Connexin 43 expression in the mouse embryo: localization of transcripts within developmentally significant domains. Dev Dynam1992; 194: 261. Crossref, Medline, Google Scholar 10 : Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: Increased expression of cardiac-type gap junction gene Connexin 43. Mol Carcin1990; 3: 273. Crossref, Medline, Google Scholar 11 : Impaired expression and posttranslational processing of Connexin43 and downregulation of gap junctional communication in neoplastic human prostate cells. Prostate1999; 38: 55. Crossref, Medline, Google Scholar 12 : Gap junction protein gene suppresses tumorigenicity. Carcinogenesis1993; 14: 1073. Crossref, Medline, Google Scholar 13 : Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J Membrane Biol1991; 124: 207. Crossref, Medline, Google Scholar 14 : Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA1991; 88: 10701. Crossref, Medline, Google Scholar 15 : Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Gen1999; 24: 91. Crossref, Medline, Google Scholar 16 : Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP. Mol Carcin1996; 15: 18. Crossref, Medline, Google Scholar 17 : Reduced Connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophy Res Com1996; 227: 64. Crossref, Medline, Google Scholar 18 : Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology1991; 129: 3187. Crossref, Medline, Google Scholar 19 : Unique features of the basal cells of human prostate epithelium. Microscop Res Tech2000; 51: 436. Crossref, Medline, Google Scholar 20 : Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinology2001; 142: 359. Crossref, Medline, Google Scholar 21 : The role of gap junctions in patterning of the chick limb bud. Development1990; 108: 623. Crossref, Medline, Google Scholar 22 : Origin and evolution of benign prostatic enlargement. Invest Urol1978; 15: 340. Medline, Google Scholar 23 : Morphological analogies of fetal prostate stroma and stromal nodules in BPH. Prostate1997; 31: 234. Crossref, Medline, Google Scholar 24 : The endocrinology and developmental biology of the prostate. Endo Rev1987; 8: 338. Crossref, Medline, Google Scholar 25 : Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci USA1997; 94: 10705. Crossref, Medline, Google Scholar 26 : Expression of the connexin43 gap junctional protein in tissues at the tip of the chick limb bud is related to the epithelial-mesenchymal interactions that mediate morphogenesis. Dev Biol1994; 161: 12. Crossref, Medline, Google Scholar 27 : Gap junctions: new tools, new answers, new questions. Neuron1991; 6: 305. Crossref, Medline, Google Scholar 28 : Expression of the gap junction protein connexin43 in embryonic chick lens: Molecular cloning, ultrastructural localization, and post-translational phosphorylation. J Mem Biol1990; 116: 163. Crossref, Medline, Google Scholar 29 : The connexin43 gene is responsive to oestrogen. Proc R Soc Lond B1994; 255: 125. Crossref, Medline, Google Scholar 30 : Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen: progesterone ratio. Endocrinology1993; 132: 2380. Crossref, Medline, Google Scholar 31 : The hormone-induced regulation of contact-dependent cell-cell communication by phosphorylation. Endo Rev1990; 11: 302. Crossref, Medline, Google Scholar 32 : Laser scanning analysis of cell-cell communication in cultured human prostate tumor cells. Anal Quan Cytol Hist1999; 21: 54. Medline, Google Scholar From the Departments of Urology and Otorhinolaryngology-Head and Neck Surgery, University of Graz, Graz, Austria, and Department of Pathology, Provident Hospital and Department of Urology, University of Illinois at Chicago, Chicago, Illinois© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited by Collins E, Bowyer C, Tsouza A and Chopra M (2022) Tomatoes: An Extensive Review of the Associated Health Impacts of Tomatoes and Factors That Can Affect Their CultivationBiology, 10.3390/biology11020239, VOL. 11, NO. 2, (239) Ray A and Mehta P (2021) Cysteine residues in the C-terminal tail of connexin32 regulate its traffickingCellular Signalling, 10.1016/j.cellsig.2021.110063, VOL. 85, (110063), Online publication date: 1-Sep-2021. Serrano-Rubi M, Jimenez L, Martinez-Rendon J, Cereijido M and Ponce A (2020) Ouabain Promotes Gap Junctional Intercellular Communication in Cancer CellsInternational Journal of Molecular Sciences, 10.3390/ijms22010358, VOL. 22, NO. 1, (358) Renaud L, Huff M, da Silveira W, Angert M, Haas M and Hardiman G Genome-Wide Analysis of Low Dose Bisphenol-A (BPA) Exposure in Human Prostate CellsCurrent Genomics, 10.2174/1389202920666190603123040, VOL. 20, NO. 4, (260-274) Asencio-Barría C, Defamie N, Sáez J, Mesnil M and Godoy A (2019) Direct Intercellular Communications and Cancer: A Snapshot of the Biological Roles of Connexins in Prostate CancerCancers, 10.3390/cancers11091370, VOL. 11, NO. 9, (1370) Li F, Pascal L, Stolz D, Wang K, Zhou Y, Chen W, Xu Y, Chen Y, Dhir R, Parwani A, Nelson J, DeFranco D, Yoshimura N, Balasubramani G, Gingrich J, Maranchie J, Jacobs B, Davies B, Hrebinko R, Bigley J, McBride D, Guo P, He D and Wang Z (2019) E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayerThe Prostate, 10.1002/pros.23806, VOL. 79, NO. 11, (1226-1237), Online publication date: 1-Aug-2019. Graham S, Jiang J and Mesnil M (2018) Connexins and Pannexins: Important Players in Tumorigenesis, Metastasis and Potential TherapeuticsInternational Journal of Molecular Sciences, 10.3390/ijms19061645, VOL. 19, NO. 6, (1645) Ray A, Katoch P, Jain N and Mehta P (2018) Dileucine-like motifs in the carboxyl tail of connexin32 control its endocytosis and assembly into gap junctionsJournal of Cell Science, 10.1242/jcs.207340 Boucher J, Monvoisin A, Vix J, Mesnil M, Thuringer D, Debiais F and Cronier L (2018) Connexins, important players in the dissemination of prostate cancer cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 10.1016/j.bbamem.2017.06.020, VOL. 1860, NO. 1, (202-215), Online publication date: 1-Jan-2018. Liu Q, Ji X, Ge Z, Diao H, Chang X, Wang L and Wu Q (2017) Role of connexin 43 in cadmium-induced proliferation of human prostate epithelial cellsJournal of Applied Toxicology, 10.1002/jat.3441, VOL. 37, NO. 8, (933-942), Online publication date: 1-Aug-2017. Han J, Liu S, Sun Z, Zhang Y, Zhang F, Zhang C, Shang D, Yang H, Su F, Xu Y, Li C, Ren H and Li X (2017) LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation methodScientific Reports, 10.1038/srep46566, VOL. 7, NO. 1 Xu N, Chen H, Chen S, Xue X, Chen H, Zheng Q, Wei Y, Li X, Huang J, Cai H and Sun X (2016) Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancerOncotarget, 10.18632/oncotarget.11231, VOL. 7, NO. 41, (67476-67484), Online publication date: 11-Oct-2016. Leithe E (2016) Regulation of connexins by the ubiquitin system: Implications for intercellular communication and cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 10.1016/j.bbcan.2016.02.001, VOL. 1865, NO. 2, (133-146), Online publication date: 1-Apr-2016. Li R, Dong X, Ma C and Liu L (2014) Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysisTheoretical Biology and Medical Modelling, 10.1186/1742-4682-11-37, VOL. 11, NO. 1, Online publication date: 1-Dec-2014. Kelsey L, Katoch P, Ray A, Mitra S, Chakraborty S, Lin M, Mehta P and Koval M (2014) Vitamin D3 Regulates the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer CellsPLoS ONE, 10.1371/journal.pone.0106437, VOL. 9, NO. 9, (e106437) Chandrasekhar A, Kalmykov E, Polusani S, Mathis S, Zucker S, Nicholson B and Ojcius D (2013) Intercellular Redistribution of cAMP Underlies Selective Suppression of Cancer Cell Growth by Connexin26PLoS ONE, 10.1371/journal.pone.0082335, VOL. 8, NO. 12, (e82335) Hejmej A, Górowska E, Kotula-Balak M, Chojnacka K, Zarzycka M, Zając J and Bilińska B (2013) Androgen Signaling Disruption during Fetal and Postnatal Development Affects Androgen Receptor and Connexin 43 Expression and Distribution in Adult Boar ProstateBioMed Research International, 10.1155/2013/407678, VOL. 2013, (1-13), . Bijnsdorp I, Rozendaal L, van Moorselaar R and Geldof A (2012) A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasisBritish Journal of Cancer, 10.1038/bjc.2012.500, VOL. 107, NO. 12, (1963-1968), Online publication date: 1-Dec-2012. Gilleron J, Carette D, Chevallier D, Segretain D and Pointis G (2012) Molecular connexin partner remodeling orchestrates connexin traffic: From physiology to pathophysiologyCritical Reviews in Biochemistry and Molecular Biology, 10.3109/10409238.2012.683482, VOL. 47, NO. 5, (407-423), Online publication date: 1-Oct-2012. Czyż J, Szpak K and Madeja Z (2012) The role of connexins in prostate cancer promotion and progressionNature Reviews Urology, 10.1038/nrurol.2012.14, VOL. 9, NO. 5, (274-282), Online publication date: 1-May-2012. Kelsey L, Katoch P, Johnson K, Batra S, Mehta P and Kyprianou N (2012) Retinoids Regulate the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer CellsPLoS ONE, 10.1371/journal.pone.0032846, VOL. 7, NO. 4, (e32846) Benko G, Spajić B, Demirović A, Štimac G, Krus̆lin B and Tomas D (2010) Prognostic value of connexin43 expression in patients with clinically localized prostate cancerProstate Cancer and Prostatic Diseases, 10.1038/pcan.2010.51, VOL. 14, NO. 1, (90-95), Online publication date: 1-Mar-2011. Pointis G, Fiorini C, Gilleron J, Carette D and Segretain D (2009) Connexins in the Male Reproductive System Connexins, 10.1007/978-1-59745-489-6_25, (495-510), . Taylor R and Risbridger G (2008) The path toward identifying prostatic stem cellsDifferentiation, 10.1111/j.1432-0436.2008.00289.x, VOL. 76, NO. 6, (671-681), Online publication date: 1-Jul-2008. Cao Z, Sun Y, Qi L, Fan L, Xiao J, Zhou L and Zhu Y (2007) Expression of connexin43 and its correlation with the expressions of Bcl-2 and Bax proteins in transitional cell carcinoma of the bladderThe Chinese-German Journal of Clinical Oncology, 10.1007/s10330-007-0117-1, VOL. 6, NO. 6, (566-570), Online publication date: 1-Dec-2007. Mol A, Geldof A, Meijer G, van der Poel H and van Moorselaar R (2007) New experimental markers for early detection of high-risk prostate cancer: role of cell–cell adhesion and cell migrationJournal of Cancer Research and Clinical Oncology, 10.1007/s00432-007-0235-8, VOL. 133, NO. 10, (687-695), Online publication date: 1-Oct-2007. Saito-Katsuragi M, Asada H, Niizeki H, Katoh F, Masuzawa M, Tsutsumi M, Kuniyasu H, Ito A, Nojima H and Miyagawa S (2007) Role for connexin 26 in metastasis of human malignant melanomaCancer, 10.1002/cncr.22894, VOL. 110, NO. 5, (1162-1172), Online publication date: 1-Sep-2007. Mitra S, Annamalai L, Chakraborty S, Johnson K, Song X, Batra S, Mehta P and Nusrat A (2006) Androgen-regulated Formation and Degradation of Gap Junctions in Androgen-responsive Human Prostate Cancer CellsMolecular Biology of the Cell, 10.1091/mbc.e06-04-0280, VOL. 17, NO. 12, (5400-5416), Online publication date: 1-Dec-2006. Brehm R, Ruttinger C, Fischer P, Gashaw I, Winterhager E, Kliesch S, Bohle R, Steger K and Bergmann M (2006) Transition from Preinvasive Carcinoma In Situ to Seminoma Is Accompanied by a Reduction of Connexin 43 Expression in Sertoli Cells and Germ CellsNeoplasia, 10.1593/neo.05847, VOL. 8, NO. 6, (499-509), Online publication date: 1-Jun-2006. Kim D, Yang E and Kim J (2006) Alterations in Calcium-Activated Potassium Channel Expressions in Human Prostate CancerKorean Journal of Urology, 10.4111/kju.2006.47.5.548, VOL. 47, NO. 5, (548), . Aasen T, Graham S, Edward M and Hodgins M (2005) Reduced expression of multiple gap junction proteins is a feature of cervical dysplasiaMolecular Cancer, 10.1186/1476-4598-4-31, VOL. 4, NO. 1, Online publication date: 1-Dec-2005. Mesnil M, Crespin S, Avanzo J and Zaidan-Dagli M (2005) Defective gap junctional intercellular communication in the carcinogenic processBiochimica et Biophysica Acta (BBA) - Biomembranes, 10.1016/j.bbamem.2005.11.004, VOL. 1719, NO. 1-2, (125-145), Online publication date: 1-Dec-2005. Pointis G, Fiorini C, Defamie N and Segretain D (2005) Gap junctional communication in the male reproductive systemBiochimica et Biophysica Acta (BBA) - Biomembranes, 10.1016/j.bbamem.2005.09.017, VOL. 1719, NO. 1-2, (102-116), Online publication date: 1-Dec-2005. Hattori Y and Maitani Y (2005) Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinaseCancer Gene Therapy, 10.1038/sj.cgt.7700844, VOL. 12, NO. 10, (796-809), Online publication date: 1-Oct-2005. Wertz K, Siler U and Goralczyk R (2004) Lycopene: modes of action to promote prostate healthArchives of Biochemistry and Biophysics, 10.1016/j.abb.2004.04.023, VOL. 430, NO. 1, (127-134), Online publication date: 1-Oct-2004. Berger J, Griend D, Stadler W and Rinker-Schaeffer C (2004) Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cellsAnti-Cancer Drugs, 10.1097/01.cad.0000132233.36512.fa, VOL. 15, NO. 6, (559-568), Online publication date: 1-Jul-2004. Siler U and Goralczyk R (2004) The Role of Lycopene in Human Health Phytochemicals in Health and Disease, 10.1201/9780203021408.ch14, (285-309), Online publication date: 24-May-2004. Sawyer T (2005) Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitorsExpert Opinion on Investigational Drugs, 10.1517/13543784.13.1.1, VOL. 13, NO. 1, (1-19), Online publication date: 1-Jan-2004. Gandhok N and Sartor O (2004) Bone-Targeted Therapy for Prostate Cancer Management of Prostate Cancer, 10.1007/978-1-59259-776-5_33, (589-606), . Segretain D, Decrouy X, Dompierre J, Escalier D, Rahman N, Fiorini C, Mograbi B, Siffroi J, Huhtaniemi I, Fenichel P and Pointis G (2003) Sequestration of connexin43 in the early endosomes: An early event of Leydig cell tumor progressionMolecular Carcinogenesis, 10.1002/mc.10160, VOL. 38, NO. 4, (179-187), Online publication date: 1-Dec-2003. Aa F, Roskams T, Blyweert W and Ridder D (2003) Interstitial cells in the human prostate: A new therapeutic target?The Prostate, 10.1002/pros.10264, VOL. 56, NO. 4, (250-255), Online publication date: 1-Sep-2003. KAUFFMAN E, ROBINSON V, STADLER W, SOKOLOFF M and RINKER-SCHAEFFER C (2018) Metastasis Suppression: The Evolving Role of Metastasis Suppressor Genes for Regulating Cancer Cell Growth at the Secondary SiteJournal of Urology, VOL. 169, NO. 3, (1122-1133), Online publication date: 1-Mar-2003. Govindarajan R, Zhao S, Song X, Guo R, Wheelock M, Johnson K and Mehta P (2002) Impaired Trafficking of Connexins in Androgen-independent Human Prostate Cancer Cell Lines and Its Mitigation by α-CateninJournal of Biological Chemistry, 10.1074/jbc.M202652200, VOL. 277, NO. 51, (50087-50097), Online publication date: 1-Dec-2002. Related articlesJournal of Urology9 Nov 2018ALTERATIONS IN GAP JUNCTION PROTEIN EXPRESSION IN HUMAN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER Volume 167Issue 2 Part 1February 2002Page: 655-660 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.Keywordsprostateprostatic neoplasmsprostatic hyperplasiaconnexinsMetrics Author Information HELGA HABERMANN More articles by this author VERA RAY More articles by this author WALTER HABERMANN More articles by this author GAIL S. PRINS Requests for reprints: Department of Urology, M/C 955, University of Illinois, Chicago, Illinois 60612. More articles by this author Expand All Advertisement PDF downloadLoading ...
Referência(s)